Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 6233 - 6240 of 11540 results
FDA Takes First Steps to Cut Regulations, Solicits Public Feedback
September 11, 2017| Blog| Viewpoint
Baker-Polito Administration Awards $455,000 in Grants to Clean Energy Innovators
September 11, 2017| Blog| Viewpoint
Washington State AG Alleges Price Fixing and Sues to Break Up Rapidly Expanding Health System
September 11, 2017| Alert| Viewpoint
Travel Ban Court Update on Family Members’ as “Bona Fide” Relationship
September 8, 2017| Alert| Viewpoint
Reminder – New Form I-9
September 8, 2017| Alert| Viewpoint
SAFEs: The (Not So) Simple Agreement for (Potential) Future Equity
September 7, 2017| Alert| Viewpoint
Monopsony and Health Plan Mergers: Does Anthem-Cigna Signal a Shift in Policy?
September 7, 2017| News
News & Press Releases
Mintz Announces Partnership with Lineal’s Amplify Technology Suite
November 19, 2024
Mintz has partnered with Lineal, a leader in legal technology and data review solutions to assist with client services delivery. The collaboration brings Lineal’s Amplify Suite—an advanced RelativityOne integration—into Mintz’s practice to enhance early data assessment (EDA), streamline modern data review, and manage strategic decision calls.
Mintz Advises Aspen Aerogels on $98M Follow-on Offering
November 19, 2024
Mintz advised Aspen Aerogels, Inc. (NYSE: ASPN), a technology leader in sustainability and electrification solutions, on a registered follow-on offering of 4,887,500 shares of its common stock, which included 637,500 shares pursuant to the underwriters’ option to purchase additional shares of its common stock. The price to the public in the offering was $20.00 per share and the gross proceeds to Aspen from the offering were approximately $98 million, before deducting underwriting discounts and commissions and estimated offering expenses.
Mintz Advises Charlesbank Capital Partners on Strategic Investment with IMPLAN Group
November 18, 2024
Mintz advised Charlesbank Capital Partners (“Charlesbank”), a middle-market private equity firm with more than $22 billion in total assets, on a strategic investment with IMPLAN Group LLC (“IMPLAN”), a leading provider of economic impact data and analytical software.